(NEOG) Neogen - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US6404911066

NEOG: Diagnostic, Test, Kits, Pharmaceuticals, Vaccines, Insecticides

Neogen Corporation (NASDAQ: NEOG) is a leader in the development, manufacturing, and marketing of products and services focused on food and animal safety. Operating through two distinct segments—Food Safety and Animal Safety—the company serves a diverse range of industries globally. The Food Safety segment specializes in diagnostic solutions to detect contaminants in food and animal feed, including pathogens, allergens, and residues. Their product portfolio includes the AccuPoint Advanced rapid sanitation test and genomics-based diagnostic technology, catering to sectors such as meat, poultry, dairy, and healthcare. This segments solutions are integral to ensuring safety across the food supply chain.

The Animal Safety segment offers a comprehensive suite of products, including veterinary instruments, pharmaceuticals, and diagnostic tools, distributed through veterinarians, retailers, and livestock producers. This segment serves various markets, from companion animals to livestock, providing essential health and safety solutions. With a market cap of approximately $2.3 billion, Neogens financials show a forward P/E of 16 and a P/S ratio of 2.54, indicating a scalable business model. The companys recurring revenue streams and global presence underscore its strategic position in the health care supplies industry, making it a significant player for investors seeking stability and growth in the safety and diagnostics sector.

Additional Sources for NEOG Stock

NEOG Stock Overview

Market Cap in USD 2,146m
Sector Healthcare
Industry Diagnostics & Research
GiC Sub-Industry Health Care Supplies
IPO / Inception 1989-08-23

NEOG Stock Ratings

Growth 5y -76.3%
Fundamental -24.1%
Dividend 0.0%
Rel. Strength Industry -41.2
Analysts 4.33/5
Fair Price Momentum 6.83 USD
Fair Price DCF -

NEOG Dividends

No Dividends Paid

NEOG Growth Ratios

Growth Correlation 3m -90.7%
Growth Correlation 12m -45.7%
Growth Correlation 5y -82.6%
CAGR 5y -19.84%
CAGR/Max DD 5y -0.24
Sharpe Ratio 12m -1.05
Alpha -53.97
Beta 1.40
Volatility 49.80%
Current Volume 3105.5k
Average Volume 20d 2375.7k
What is the price of NEOG stocks?
As of March 15, 2025, the stock is trading at USD 9.05 with a total of 3,105,509 shares traded.
Over the past week, the price has changed by -12.98%, over one month by -7.93%, over three months by -23.63% and over the past year by -40.66%.
Is Neogen a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Neogen is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -24.12 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NEOG as of March 2025 is 6.83. This means that NEOG is currently overvalued and has a potential downside of -24.53%.
Is NEOG a buy, sell or hold?
Neogen has received a consensus analysts rating of 4.33. Therefor, it is recommend to buy NEOG.
  • Strong Buy: 2
  • Buy: 0
  • Hold: 1
  • Sell: 0
  • Strong Sell: 0
What are the forecast for NEOG stock price target?
According to ValueRays Forecast Model, NEOG Neogen will be worth about 7.5 in March 2026. The stock is currently trading at 9.05. This means that the stock has a potential downside of -16.8%.
Issuer Forecast Upside
Wallstreet Target Price 14 54.7%
Analysts Target Price 15.8 74%
ValueRay Target Price 7.5 -16.8%